Joe McGrath • April 10, 2017
A fintech campus in the City of London is set to rival Canary Wharf’s Level 39.
Jeffrey Kutler • April 10, 2017
After WikiLeaks published techniques used by the CIA for breaking into smartphones, the biggest leak in the spy agency’s history faded away.
Joe McGrath • April 05, 2017
The electric carmaker’s soaring market value has sparked debate over ‘ethical’ holdings in environmental, social and governance strategies.
Joe McGrath • April 03, 2017
Pressure to cut costs by replacing humans with robots may end up hurting firms if they’re not careful, PwC says.
Staff • March 29, 2017
Stock exchanges and other market infrastructure firms are carving out a larger share of revenue in financial services, McKinsey says.
Joe McGrath • March 28, 2017
The U.K. fund manager says the odds of leaving the trading bloc without a trade deal are “sufficiently high to worry.”
Staff • March 27, 2017
The bronze sculpture promoting SSGA’s gender balance campaign was granted an extended permit by New York City Mayor Bill de Blasio.
Jeffrey Kutler • March 27, 2017
The SEC and deputy director of its economic and risk analysis division stand out as regulatory technology innovators.
The Editors • March 22, 2017
David Rubenstein's Carlyle Group raised immense amounts of capital on the back of its famous board members. Then, the co-founder recounts, it made a lot of money for its investors.
Joe McGrath • March 21, 2017
Concerns are mounting that portfolios may lack resilience against global event risks.
Julie Segal • March 20, 2017
State Street Global Advisors used a savvy social media campaign to call attention to its “Fearless Girl” campaign — and its SHE ETF product.
Vitaliy Katsenelson • March 08, 2017
In my previous column I explained why we are partial to pharmaceuticals, a sector politicians love to hate. Here’s how we’re playing our view.
The Editors • March 08, 2017
Kepos Capital's Mark Carhart recalls the fraught atmosphere of 1998, when the seemingly infallible Long Term Capital Management blew up spectacularly – and nearly took down global capital markets.
Jeffrey Kutler • March 07, 2017
Institutional Investor's annual ranking of the top trading technologists on the planet.
Vitaliy Katsenelson • March 02, 2017
Pharmaceuticals stocks have been in the crosshairs of politicians on both sides of the aisle. But the noise has created buying opportunities.
© 2017 Institutional Investor LLC. All material subject to strictly enforced copyright laws.
Please read our
Term and Conditions and